Chapter 7 – Pharmacological fMRI 249 33. BromM, Laan E, Everaerd W, Spinhoven P, Trimbos B, Both S. d-Cycloserine reduces context specificity of sexual extinction learning. Neurobiology of Learning and Memory. 2015;125:202-210. doi:10.1016/J.NLM.2015.09.010 34. Thomaidou MA, Peerdeman KJ, Koppeschaar MI, Evers AWM, Veldhuijzen DS. How Negative Experience Influences the Brain: A Comprehensive Review of the Neurobiological Underpinnings of Nocebo Hyperalgesia. Frontiers in Neuroscience. 2021;15. doi:10.3389/fnins.2021.652552 35. Faul F, Erdfelder E, Lang AG. G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behavior Research Methods. 2007;39(2):175-191. doi:10.3758/BF03193146 36. Kennedy JJ. THE ETA COEFFICIENT IN COMPLEX ANOVA DESIGNS. Vol 30. Cohen; 1970. 37. Cohen J. ETA-SQUARED AND PARTIAL ETA-SQUARED IN FIXED FACTOR ANOVA DESIGNS.; 1973. 38. Rolke R, Magerl W, Campbell KA, et al. Quantitative sensory testing: a comprehensive protocol for clinical trials. European Journal of Pain. 2006;10(1):77-88. doi:10.1016/J.EJPAIN.2005.02.003 39. D’Souza DC, Gil R, Cassello K, et al. IV glycine and oral d-cycloserine effects on plasma and CSF amino acids in healthy humans. Biological Psychiatry. 2000;47(5):450462. doi:10.1016/S0006-3223(99)00133-X 40. Meftah A, Hasegawa H, Kantrowitz JT. D-Serine: A Cross Species Review of Safety. Frontiers in Psychiatry. 2021;12:1346. doi:10.3389/fpsyt.2021.726365 41. Wechsler D. Wechsler Adult Intelligence Scale–Fourth Edition (WAIS–IV).; 2014. 42. First M, Williams JBW, Karg RS, Spitzer RL. The Structured Clinical Interview for the DSM-5, Research Version (SCID-RV). American Psychiatric Association; 2015. https://www.columbiapsychiatry.org/research/research-labs/diagnostic-andassessment-lab/structured-clinical-interview-dsm-disorders-14 43. Marteau TM, Bekker H. The development of a six-item short-form of the state scale of the Spielberger State-Trait Anxiety Inventory (STAI). British Journal of Clinical Psychology. 1992;31(3):301-306. doi:10.1111/j.2044-8260.1992.tb00997.x 44. Spielberger C, Gorsuch R, Lushene P, Vagg P, Jacobs A. Manual for the StateTrait Anxiety Inventory STAI (Form Y) (“Self-Evaluation Questionnaire”). In: Man StateTrait Anxiety Invent STAI. Consulting Psychologists Press, Inc.; 1983:4-6. 45. Sullivan M, Bishop S, Pivik J. The Pain Catastrophizing Scale: Development and validation. Psychological Assessment. 1995;7(4):524-532. 46. Crombez G, De Paepe AL, Veirman E, Eccleston C, Verleysen G, Van Ryckeghem DML. Let’s talk about pain catastrophizing measures: an item content analysis. PeerJ. 2020;8:e8643. doi:10.7717/peerj.8643 47. Schmid NB, Lerew DR, Trakowski JH. Body vigilance in panic disorder: Evaluating attention to bodily perturbations. Journal of Consulting and Clinical Psychology,. 1997;65(2):214-220. doi:10.1037/0022-006X.65.2.214 48. Venables WN, Ripley BD. Modern Applied Statistics with S - MASS. 4th ed. Springer; 2002. https://www.stats.ox.ac.uk/pub/MASS4/ 49. Hlavac M. stargazer: Well-Formatted Regression and Summary Statistics Tables. R package version 5.2.2. Published online 2018. https://CRAN.Rproject.org/package=stargazer 50. Wickham H. Ggplot2: Elegant Graphics for Data Analysis. Springer-Verlag; 2016. https://ggplot2.tidyverse.org
RkJQdWJsaXNoZXIy MTk4NDMw